Bryan Garnier - Worldline (WLN) Q1 revenue a touch above expectations, outlook confirmed

Report

Bryan Garnier

Paul Charpentier

Q1 revenue a touch above expectations, outlook confirmed

This morning's resilient Q1 2023 revenue figures of +9.2% Y/Y slightly exceed consensus expectations by 1.2%. The reiterated guidance pointing to +8-10% LFL revenue growth in FY 2023e, at par with market estimates, seems largely achievable. BUY, €61.00 PT confirmed.

26/04/2023 1 EN

Underlying

Worldline

See profile

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Paul Charpentier

Other Reports on these Companies

Bryan Garnier

Have payments hit bottom yet?

In October 2023, we adopted a negative view on the payment sector, citing commoditisation risks and a bleak macroeconomic outlook as threats to the companies in our coverage. While commoditisation remains a concern, we are now more optimistic about the macro environment. To answer the initial quest

June 27, 2024 June 27, 2024 1 EN

Bryan Garnier

Have payments hit the bottom yet ? - Worldline

In October 2023, we adopted a negative view on the payment sector, citing commoditization risks and a bleak macroeconomic outlook as threats to the companies in our coverage. While commoditization remains a concern, we are now more optimistic about the macro. To answer the initial question, we beli

June 27, 2024 June 27, 2024 1 EN

Bryan Garnier

Worldline - not as weak as expected, but too early to jump in

Worldline reported 2.5% organic growth in Q1 2024, weak in absolute terms but better than anticipated by the market and us. We wait for a clear uptick in momentum and the confirmation of an improved profitability to turn positive on the stock; which is arguably far from expensive at 5.1x EV/NTM EBI

May 2, 2024 May 2, 2024 1 EN

Afyren: All lights are green

Founded in 2014, Afyren is a green chemistry company producing sustainable carboxylic acids via anaerobic fermentation. The company's technology platform enables the production of a family of seven organic acids and one fertilizer using non-food biomass (sugar pulp and molasses) through the masteri

1h / 41m 1h / 41m 1 EN

Antoine Lebourgeois

Antoine Lebourgeois

SES: model update pre-Q2 2024

We have revised our estimates ahead of Q2 2024 results. Our updated estimates are detailed in the table below. Our Buy recommendation remains unchanged, as we continue to consider the shares undervalued and view the attractive dividend yield as limiting downside risk. Our PT has been revised to EUR

July 3, 2024 July 3, 2024 1 EN

Maria Vara

Maria Vara

BONESUPPORT: CERAMENT V to enter the US in Q2 2025 instead of H2

Yesterday, during trading hours, BONESUPPORT announced that CERAMENT V will follow the 510(k) FDA path instead of De Novo, positively shortening the time to market to Q2 2025 instead of YE 2025. Such a decision coming from the FDA is backed by the fact that CERAMENT V (vancomycin), despite having a

July 2, 2024 July 2, 2024 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Q1 revenue a touch above expectations, outlook confirmed

Have payments hit bottom yet?

Have payments hit the bottom yet ? - Worldline

Worldline - not as weak as expected, but too early to jump in

Afyren: All lights are green

SES: model update pre-Q2 2024

BONESUPPORT: CERAMENT V to enter the US in Q2 2025 instead of H2

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe